test

Alexandra Toohey

@Baker Bros. Advisors Lp

Latest period2024 - Q3ReportedManaged Assets$9.649BTotal holdings93
Assets growth rate23.31%Assets growth rate (2-Q avg)10.74%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Baker Bros. Advisors Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 93 positions.

Assets under management

The assets under management (AUM) of Baker Bros. Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 9.649B in assets, with a quarterly growth rate of 23.31% and a 2-quarter average growth rate of 10.74%. The portfolio is managed by Alexandra Toohey, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
EWTXEdgewise Therapeutics, Inc.
Recent Activity
1.62%
$155.871M
5.84M shares@ $26.7 avg price
REPLReplimune Group, Inc.
Recent Activity
Increased 9.96%
1.26%
$121.057M
11.045M shares@ $10.97 avg price
ALKSAlkermes Plc
Recent Activity
1.22%
$117.047M
4.182M shares@ $27.99 avg price
DNLIDenali Therapeutics Inc.
Recent Activity
1.13%
$108.704M
3.732M shares@ $29.13 avg price
4576⤦Insmed Incorporated
Recent Activity
1.02%
$98.325M
42.85M shares@ $2.3 avg price
RAREUltragenyx Pharmaceutical Inc.
Recent Activity
Increased 7.48%
0.91%
$87.553M
1.576M shares@ $55.56 avg price
NRIXNurix Therapeutics, Inc.
Recent Activity
0.91%
$87.231M
3.882M shares@ $22.48 avg price
TRDAEntrada Therapeutics, Inc.
Recent Activity
0.81%
$77.756M
4.866M shares@ $15.99 avg price
IMTXImmatics N.v.
Recent Activity
0.77%
$73.519M
6.443M shares@ $11.41 avg price
ABCLAbcellera Biologics Inc.
Recent Activity
0.75%
$71.567M
27.526M shares@ $2.6 avg price